ESTRO Annual Report 2018

administrative and/or financial staff fromparticle centres would be a better representation of the users’ perspective in this work party.

ENLIGHT Due to the similarity of work between the EPTN and the European Network for Light Ion Hadron Therapy (ENLIGHT) originally launched by ESTRO in 2000 was highlighted. It was decided to explore and draw up a collaborative agreement to benefit both networks. INSPIRE INfraStructure in Proton International Research (INSPIRE), funded by the European Commission, complements EPTN activities and so collaboration on: networking, transnational access and joint research activities could benefit EPTN’s WP2, 5 and 6. An update of activities of WPs will be given at the next annual meeting of EPTN on 9 April 2019 in Brussels at the ESTRO office..

EPTN Collaborative efforts

PTCOG ESTRO and EPTN signed a memorandum of understanding with the Particle Therapy Co- Operative Group (PTCOG) to collaborate on education, meetings and scientific exchange. EORTC EORTC and ESTRO launched the E2-RADIatE (EORTC-ESTRO Radiation Infrastructure for Europe), a platformaimed at generating robust data that can be shared to improve clinical research and ultimately cancer treatment. EPTN’s ParticleCARE project falls under this infrastructure.

References Publications in: Radiotherapy & Oncology Vol 128, July 2018 (Special issue on Proton Therapy): [1]Optimizingclinicalresearchandgeneratingprospectivehigh-quality data in particle therapy in Europe: Introducing the European Particle TherapyNetwork(EPTN).CaiGrau,MichaelBaumann,DamienCharles Weber DOI: https://doi.org/10.1016/j.radonc.2018.06.021 [2] The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology. Daniëlle BP Eekers, Lieke in ‘t Ven, Erik Roelofs, Alida Postma, Claire Alapetite, Neil G. Burnet, Valentin Calugaru, Inge Compter,IdaE.M.Coremans,MortonHøyer,MaartenLambrecht,Petra Witt Nyström, Alejandra Méndez Romero, Frank Paulsen, Ana Perpar, Dirk de Ruysscher, Laurette Renard, Beate Timmermann, Pavel Vitek, Damien C. Weber, Hiske L. van der Weide, Gillian A. Whitfield, Ruud Wiggenraad, Esther G.C. Troost on behalf of the taskforce “European Particle Therapy Network” of ESTRODOI: https://doi.org/10.1016/j. radonc.2017.12.013

DaniëlleB.P.Eekers,ClaireAlapetite,NeilG.Burnet,ValentinCalugaru, IdaE.M.Coremans,PieroFossati,MortenHøyer,JohannesA.Langendijk, AlejandraMéndezRomero,FrankPaulsen,AnaPerpar,LauretteRenard, Dirk de Ruysscher, Beate Timmermann, Pavel Vitek, Damien C. Weber, Hiske L. van der Weide, Gillian A. Whitfield, Ruud Wiggenraad, Erik Roelofs,PetraWittNyström,EstherG.C.Troostonbehalfofworkpackage 1 of the taskforce “European Particle Therapy Network” of ESTRO DOI: https://doi.org/10.1016/j.radonc.2018.05.001 [4] Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. DamienC.Weber,JeanLouisHabrand,BradfordS.Hoppe,ChristineHill Kayser,NadiaN.Laack,JohanesA.Langendijk,ShannonM.MacDonald, SusanL.McGovern,LukePater,JohnP.Perentesis,JulietteThariat,Beate

Timmerman, Torunn I. Yock, Anita Mahajan DOI: https://doi.org/10.1016/j.radonc.2018.05.020

[3] Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus. Maarten Lambrecht,

[5]Prospectivedataregistrationandclinical trials forparticle therapy in Europe.JohannesA.Langendijk,RobertoOrecchia,KarinHaustermans,

67

Science Dissemination